Lataa...
Estimation of the Percentage of US Patients With Cancer Who Are Eligible for and Respond to Checkpoint Inhibitor Immunotherapy Drugs
IMPORTANCE: Immunotherapy checkpoint inhibitors have generated considerable interest because of durable responses in a number of hitherto intractable tumor types. OBJECTIVE: To estimate the percentage of patients with cancer in the United States who are eligible for and respond to checkpoint inhibit...
Tallennettuna:
| Julkaisussa: | JAMA Netw Open |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
American Medical Association
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6503493/ https://ncbi.nlm.nih.gov/pubmed/31050774 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2019.2535 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|